Log In
person
SIGA Technologies Inc
SIGA
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Infectious disease drugs |
Vaccines (outsourced)
These companies research, develop, and outsource the manufacturing of vaccines.
|
130.67M | 93.39% |
| Infectious disease drugs |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
9.25M | 6.61% |
| keyboard_arrow_down |
Infectious disease drugs
Vaccines (outsourced)
|
130.67M | 93.39% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of vaccines.
|
||
| keyboard_arrow_down |
Infectious disease drugs
Pre-Revenue Pharmaceuticals
|
9.25M | 6.61% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||